Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Similares en SciELO
Compartir
Gaceta mexicana de oncología
versión On-line ISSN 2565-005Xversión impresa ISSN 1665-9201
Resumen
TELLEZ-BANUELOS, Martha C. et al. Immunotherapy in prostate cancer: fundamentals and opportunities for its application in the clinic. Gac. mex. oncol. [online]. 2023, vol.22, n.3, pp.130-139. Epub 29-Sep-2023. ISSN 2565-005X. https://doi.org/10.24875/j.gamo.23000123.
Radiotherapy, androgen deprivation therapy, and chemotherapy are the mainstay of treatment for prostate cancer; however, resistance development significantly limits their efficacy. Chronic inflammation has a major role in the process of carcinogenesis, and there is a suppression of immune response in prostate cancer. Thereby, immunotherapy represents a promising therapeutic tool as it can potentiate the immune response against the tumor. Multiple clinical trials evaluate the efficacy and utility of immunotherapy in this cancer, which will be discussed in this review.
Palabras llave : Prostatic neoplasms; Immunotherapy; Immunology.